JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.6% |
| 2 | Financials | 12.17% |
| 3 | Healthcare | 9.21% |
| 4 | Consumer Discretionary | 8.57% |
| 5 | Industrials | 6.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5026
Donegal Group Class A
DGICA
$693M
| $43K | ﹤0.01% |
2,836
-10,661
| -79% | -$150K |
|
5027
Franklin Financial Services
FRAF
$284M
| $43K | ﹤0.01% |
+1,151
| New | +$44.2K |
|
5028
Marchex
MCHX
$77.1M
| $43K | ﹤0.01% |
9,524
-40,523
| -81% | -$194K |
|
5029
MainStreet Bancshares
MNSB
$174M
| $43K | ﹤0.01% |
+1,950
| New | +$46.1K |
|
5030
MVB Financial
MVBF
$392M
| $43K | ﹤0.01% |
2,592
+503
| +24% | +$8.21K |
|
5031
Ohio Valley Banc Corp
OVBC
$208M
| $43K | ﹤0.01% |
1,137
-1,370
| -55% | -$51.4K |
|
5032
Schwab US Broad Market ETF
SCHB
$44.7B
| $43K | ﹤0.01% |
3,666
-3,168
| -46% | -$36.6K |
|
5033
Sportsman's Warehouse
SPWH
$46.8M
| $43K | ﹤0.01% |
11,656
-171,347
| -94% | -$729K |
|
5034
Tiptree Inc
TIPT
$671M
| $43K | ﹤0.01% |
6,831
+356
| +5% | +$2.19K |
|
|
TBCH
5035
Turtle Beach Corp
TBCH
$256M
| $43K | ﹤0.01% |
3,700
-85,187
| -96% | -$902K |
|
|
ENZ
5036
DELISTED
Enzo Biochem, Inc.
ENZ
| $43K | ﹤0.01% |
12,121
+1,377
| +13% | +$4.85K |
|
|
PBIP
5037
DELISTED
Prudential Bancorp, Inc.
PBIP
| $43K | ﹤0.01% |
2,403
+237
| +11% | +$4.13K |
|
|
CNST
5038
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $43K | ﹤0.01% |
4,246
+398
| +10% | +$4.43K |
|
5039
Abeona Therapeutics
ABEO
$422M
| $42K | ﹤0.01% |
354
+49
| +16% | +$8.21K |
|
|
ALLK
5040
CALL
DELISTED
Allakos
ALLK
| $42K | ﹤0.01% |
+1,000
| New | +$41K |
|
|
CLPR
5041
Clipper Realty
CLPR
$47M
| $42K | ﹤0.01% |
3,958
-33,082
| -89% | -$426K |
|
5042
FTAI Aviation
FTAI
$23.2B
| $42K | ﹤0.01% |
+3,261
| New | +$44.5K |
|
5043
Great Elm Capital Corp
GECC
$78.2M
| $42K | ﹤0.01% |
800
-500
| -38% | -$25.8K |
|
5044
Medallion Financial
MFIN
$253M
| $42K | ﹤0.01% |
6,614
+4,414
| +201% | +$30.3K |
|
5045
Novavax
NVAX
$1.31B
| $42K | ﹤0.01% |
6,833
-62,195
| -90% | -$489K |
|
5046
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.09B
| $42K | ﹤0.01% |
2,049
-21,468
| -91% | -$460K |
|
|
SBBP
5047
DELISTED
Strongbridge Biopharma plc.
SBBP
| $42K | ﹤0.01% |
+12,941
| New | +$47.5K |
|
|
DNBF
5048
DELISTED
DNB Financial Corp
DNBF
| $42K | ﹤0.01% |
954
-345
| -27% | -$14.2K |
|
|
STEX
5049
Streamex Corp
STEX
$83M
| $41K | ﹤0.01% |
430
+380
| +760% | +$27.6K |
|
5050
Galectin Therapeutics
GALT
$316M
| $41K | ﹤0.01% |
10,136
-178,555
| -95% | -$773K |
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,669 increased, 2,117 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.